New hope for battling Brain-Invading lymphoma
NCT ID NCT03964090
Summary
This study is testing a combination of six drugs, called TEDDI-R, to treat aggressive B-cell lymphoma that has spread to the central nervous system (brain, spinal cord, or eyes). The goal is to see if this new regimen can better control the cancer and help patients live longer without their disease getting worse. The treatment involves up to four cycles of therapy over several months and is for adults whose lymphoma has come back or is newly diagnosed with this specific spread.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.